Ticker Details
ImmunityBio, Inc. Common Stock
IPO Date:	July 27, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$7.44B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.98%
Avg Daily Range (30 D):	$0.21 | 2.78%
Avg Daily Range (90 D):	$0.41 | 5.16%

Institutional Daily Volume
Avg Daily Volume:	2.85M
Avg Daily Volume (30 D):	12.77M
Avg Daily Volume (90 D):	21.37M

Trade Size
Avg Trade Size (Sh.):	257
Avg Trade Size (Sh.) (30 D):	241
Avg Trade Size (Sh.) (90 D):	274

Institutional Trades
Total Institutional Trades:	2,011
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$2.34M
Avg Institutional Trade (90 D):	$1.89M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.31M
Avg Closing Trade (30 D):	$5.59M
Avg Closing Trade (90 D):	$6.04M
Avg Closing Volume:	434.63K

News

May 26, 2026 @ 8:00 PM INVESTOR ALERT: Pomerantz Law Firm Reminds Investo... Source: Pomerantz Llp

May 25, 2026 @ 11:22 PM IBRX DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR... Source: Rosen Law Firm

May 25, 2026 @ 1:48 PM IBRX Investors Have Opportunity to Lead ImmunityBi... Source: The Schall Law Firm

May 22, 2026 @ 10:11 PM IBRX DEADLINE NOTICE: ROSEN, NATIONALLY REGARDED I... Source: Rosen Law Firm

May 22, 2026 @ 4:48 PM IBRX 4-DAY DEADLINE ALERT: ImmunityBio (IBRX) Inve... Source: Hagens Berman

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.85	$-.62	$-.06
Diluted EPS	$-.85	$-.62	$-.06
Revenue	$140.98M	$44.21M	$38.29M
Gross Profit	$140.04M	$43.97M	$37.9M
Net Income / Loss	$-854.6M	$-632.8M	$-61.96M
Operating Income / Loss	$-261.39M	$-69.79M	$-64.68M
Cost of Revenue	$.93M	$.24M	$.38M
Net Cash Flow	$145.18M	$116.92M	$28.09M
PE Ratio